Literature DB >> 1801332

Pharmacokinetics of quinine in young and elderly subjects.

S Wanwimolruk1, S Chalcroft, P F Coville, A J Campbell.   

Abstract

The effect of age on the pharmacokinetics of quinine was investigated by comparing its kinetic behaviour in 12 young healthy adults and 8 healthy elderly subjects after a single 600 mg oral dose of quinine sulphate. Peak plasma quinine concentration and the time of peak concentration were similar in the young and elderly subjects. The mean oral clearance of quinine was found to be significantly decreased in the elderly (P less than 0.05, 0.062 litre/h/kg vs 0.084 litre/h/kg) as compared to the young. This was accompanied by a significant increase in the mean elimination half-life of quinine in the elderly group (18.4 +/- 5.7 [standard deviation] h vs 10.5 +/- 1.6 h, P less than 0.05). There was no significant difference in the renal clearance of quinine between the young and the elderly (P greater than 0.05). However, elderly subjects excreted 16.6 +/- 3.7% of the dose as unchanged quinine in the urine and this was significantly greater (P less than 0.005) than the amount excreted by the young (11.2 +/- 2.5%). The results of this study indicate that the elimination processes for quinine are impaired in normal elderly subjects. The clinical significance of these findings is unknown, but they indicate the need for caution in the administration of quinine to elderly patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801332     DOI: 10.1016/0035-9203(91)90423-v

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

Review 1.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 3.  Grapefruit-drug interactions.

Authors:  Kay Seden; Laura Dickinson; Saye Khoo; David Back
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

4.  Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Authors:  S Wanwimolruk; W Kang; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

5.  Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

Authors:  Sompon Wanwimolruk; Mary F Paine; Susan N Pusek; Paul B Watkins
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

6.  The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.

Authors:  J R Dyer; T M Davis; C Giele; T Annus; P Garcia-Webb; J Robson
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

7.  Cigarette smoking enhances the elimination of quinine.

Authors:  S Wanwimolruk; S M Wong; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

8.  Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang
Journal:  Malar J       Date:  2022-02-10       Impact factor: 2.979

9.  Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2.

Authors:  Paul Oranje; Robin Gouka; Lindsey Burggraaff; Mario Vermeer; Clément Chalet; Guus Duchateau; Pieter van der Pijl; Marian Geldof; Niels de Roo; Fenja Clauwaert; Toon Vanpaeschen; Johan Nicolaï; Tom de Bruyn; Pieter Annaert; Adriaan P IJzerman; Gerard J P van Westen
Journal:  Pharmacol Res Perspect       Date:  2019-07-30

10.  Quinine exposure and the risk of acute kidney injury: a population-based observational study of older people.

Authors:  Andrew D S Duncan; Simona Hapca; Nicosha De Souza; Daniel Morales; Samira Bell
Journal:  Age Ageing       Date:  2020-10-23       Impact factor: 10.668

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.